Results 131 to 140 of about 3,889 (160)

I. Review of Immune-mediated Necrotizing Myopathy

Nihon Naika Gakkai Zasshi
Rui Shimazaki, Ichizo Nishino
openaire   +1 more source

Steroid-Responsive Seronegative Immune-Mediated Necrotizing Myopathy Likely Triggered by Coxsackie B Virus: A Case Report. [PDF]

Cureus
Kumar M, Ali SM, Kumar V, Alsibai A, Parkash O.   +4 more
europepmc   +1 more source

Diffuse Large B-cell Lymphoma Complicated with Anti-3-hydroxy-3-methylglutaryl-Coenzyme A Reductase Immune-mediated Necrotizing Myopathy. [PDF]

Intern Med
Tokunaga Y, Akiyama M, Nakano K, Konaka K, Taguchi A, Maeda T, Sato R, Kanda T, Nakamura Y, Yujiri T, Ohta Y.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Granulomatous myopathy co-existent immune-mediated necrotizing myopathy: A case report

Clinical Neurology and Neurosurgery, 2023
Granulomatous myopathy (GM) is a rare disease characterized by non-caseating inflammation of the skeletal muscle, with sarcoidosis as a common cause. Here, we report a case of GM co-existent immune-mediated necrotizing myopathy (IMNM) in which an anti-signal recognition particle (SRP) antibody was positive and a muscle biopsy showed a non-caseating ...
Danfeng Zheng
exaly   +3 more sources

Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge

Autoimmunity Reviews, 2022
This review is focused on the myopathological spectrum of immune mediated necrotizing myopathies (IMNMs) and its differentiation with other, potentially mimicking, inflammatory and non-inflammatory myopathies. IMNMs are a subgroup of idiopathic inflammatory myopathies (IIMs) characterized by severe clinical presentation with rapidly progressive ...
Merlonghi G., Antonini G., Garibaldi M.
openaire   +2 more sources

Immune-mediated necrotizing myopathy

Zeitschrift für Rheumatologie, 2016
Immune-mediated necrotizing myopathy (IMNM) is a newly identified subgroup of idiopathic inflammatory myopathies. It is defined as a rare and severe disease, with symmetrical and proximal muscle weakness and a characteristic histology. An autoimmune aspect of IMNM is suggested by its association with autoantibodies directed against signal recognition ...
C, Bergua, H, Chiavelli, J P, Simon, O, Boyer, F, Jouen, W, Stenzel, J, Martinet   +6 more
openaire   +2 more sources

Immune-Mediated Necrotizing Myopathy

Journal of Clinical Images
A 70-year-old male with a two-year history of weakness and dysphagia was diagnosed with immune-mediated necrotizing myopathy (IMNM) (Figure 1) confirmed by biopsy and SRP autoantibody positivity.
Wafa Elgeadi Saleh, Sergio Prieto-González   +1 more
  +5 more sources

Immune‐mediated necrotizing myopathy associated with statins

Muscle & Nerve, 2009
Abstract We report patients from two neuromuscular centers who were evaluated between the years 2000 and 2008 and met the following criteria: (1) proximal muscle weakness occurring during or after treatment with statins; (2) elevated serum creatine kinase (CK); (3) persistence of weakness and elevated CK despite discontinuation of the
Phyllis, Grable-Esposito, Hans D, Katzberg, Steven A, Greenberg, Jayashri, Srinivasan, Jonathan, Katz, Anthony A, Amato   +5 more
openaire   +2 more sources

Spectrum of immune-mediated necrotizing myopathies and their treatments

Current Opinion in Rheumatology, 2016
Purpose of reviewThis review aims to describe the spectrum of clinical, histological, and serological features in patients with immune-mediated necrotizing myopathies (IMNMs).Recent findingsAutoantibodies recognizing the signal recognition particle (SRP) or 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) define two unique subtypes of necrotizing ...
Iago, Pinal-Fernandez, Andrew L, Mammen
openaire   +2 more sources

Management of immune‐mediated necrotizing myopathy

Muscle & Nerve
AbstractThe immune‐mediated necrotizing myopathies (IMNM) are autoimmune myositides clinically characterized by proximal predominant weakness and elevated creatine kinase (CK). They may be associated with autoantibodies (anti‐HMGCR, anti‐SRP), triggered by statin use (e.g., anti‐HMGCR myopathy), associated with cancer, or may be idiopathic ...
Joome, Suh, Anthony A, Amato
openaire   +2 more sources